Triazole-Linked Sesamol Conjugates as Antifungal Agents Targeting CYP51

A series of triazole-linked sesamol-based conjugates designed as antifungal agents against Candida albicans. The dataset includes synthesized compounds evaluated for anti-Candida efficacy, with compound CH3 showing the highest activity. It was authored by Karanvir Singh and last updated on 2026-04-28.

Use Cases

• Structure-based optimization of antifungal compounds based on the e-pharmacophore and molecular hybridization approach described.
• Evaluating antifungal efficacy and resistance profiles based on MIC and MFC values for a panel of Candida strains.
• Assessing biofilm eradication activity and in vivo safety profiles in a Galleria mellonella infection model.

Strengths

• Includes specific efficacy metrics for a lead compound (CH3) with MIC = 1.9 μM and MFC = 3.9 μM.
• Describes a 30-day resistance induction assay where drug resistance was not observed.
• Reports in vivo safety and efficacy data from a Galleria mellonella infection model.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The dataset is small in scale at 632.9 KB, indicating limited scope.

Provenance

Source

figshare

Collection Method

Compounds were designed using an integrated e-pharmacophore and molecular hybridization approach, then synthesized and evaluated.

Freshness

Last updated 2026-04-28 06:33:43; freshness should be verified.